Update on the management of diabetic retinopathy: Anti-VEGF agents for the prevention of complications and progression of nonproliferative and proliferative …

TA Bahr, SJ Bakri - Life, 2023 - mdpi.com
Diabetic retinopathy (DR) is a microvascular disease caused by poorly controlled blood
glucose, and it is a leading cause of vision loss in people with diabetes. In this review we …

Anti‐vascular endothelial growth factor for proliferative diabetic retinopathy

MJ Martinez-Zapata, I Salvador… - Cochrane Database …, 2023 - cochranelibrary.com
Background Proliferative diabetic retinopathy (PDR) is an advanced complication of diabetic
retinopathy that can cause blindness. It consists of the presence of new vessels in the retina …

Heterotypic macrophages/microglia differentially contribute to retinal ischaemia and neovascularisation

M Yamaguchi, S Nakao, M Arima, K Little, A Singh… - Diabetologia, 2024 - Springer
Aims/hypothesis Diabetic retinopathy is characterised by neuroinflammation that drives
neuronal and vascular degenerative pathology, which in many individuals can lead to retinal …

Secretogranin III selectively promotes vascular leakage in the deep vascular plexus of diabetic retinopathy

L Ji, P Waduge, Y Wu, C Huang, A Kaur… - International Journal of …, 2023 - mdpi.com
Diabetic retinopathy (DR), a leading cause of vision loss in working-age adults, induces
mosaic patterns of vasculopathy that may be associated with spatial heterogeneity of …

Assessment of Baseline Ultrawidefield Fluorescein Angiographic Quantitative Leakage Parameters with Ultrawidefield Fundus Features and Clinical Parameters in …

JP Ehlers, K Josic, S Yordi, A Martin, SK Srivastava… - Ophthalmology …, 2024 - Elsevier
Purpose Evaluate quantitative leakage parameters on ultrawidefield fluorescein
angiography (UWF-FA) images and explore their association with Diabetic Retinopathy …

A Literary Pediatric Retina Fellowship With Michael T. Trese, MD

EH Wood, DM Moshfeghi, A Capone Jr… - … Surgery, Lasers and …, 2023 - journals.healio.com
Michael T. Trese, MD (1946–2022), a vitreoretinal surgeon, made significant contributions to
the field of retina. Although most known for his work in pediatric retina surgery, he was a …

[HTML][HTML] Wide field imaging biomarkers: A different perspective

S Shiromani, N Pattathil, E Sadeghi… - Taiwan Journal of …, 2024 - journals.lww.com
Wide field retinal imaging has emerged as a transformative technology over the last few
decades, revolutionizing our ability to visualize the intricate landscape of the retina. By …

Reperfusion of retinal nonperfusion by neovascular-vascular anastomosis in proliferative diabetic retinopathy

A Shiraki, K Tsuboi, T Wakabayashi… - European Journal …, 2024 - journals.sagepub.com
Background Retinal nonperfusion is a significant cause of vision loss in patients with
proliferative diabetic retinopathy (PDR). Therefore, reperfusion of a nonperfusion has been a …

Characteristics of Non-Responders in Diabetic Retinopathy

S Halim - 2023 - discovery.ucl.ac.uk
Diabetic retinopathy (DR) is the commonest microvascular complication of diabetes and the
commonest cause of preventable blindness in working-aged adults globally. The prevalence …

Anti-vascular endothelial growth factor (anti-VEGF): its function in proliferative diabetic retinopathy management

C Scerbatiuc - Revista de Ştiinţe ale Sănătăţii din Moldova, 2024 - ibn.idsi.md
Introduction. Among working-age adults, diabetes is a primary cause of visual impairment.
Pan-retinal photocoagulation, the standard treatment for proliferative diabetic retinopathy, is …